<https://www.360dx.com/infectious-disease/renalytixai-prices-743m-us-ipo-private-placement>
<http://schema.org/description>
"The firm intends to use about $25 million to $30 million of the net proceeds for the continued development and planned commercialization of its KidneyIntelX platform."
<https://www.360dx.com/infectious-disease/renalytixai-prices-743m-us-ipo-private-placement>